The extended provider choice reform - effects on interdisciplinary specialized drug treatments in Health Region South East

I will be researching the Extended provider choice reform(EPC), from 2015, and the main goals of this reform(1). These goals were stated by the health minister of Norway to be: reduce waiting times, use available capacity, allow private and public providers to treat more patients in total, and last but not least to increase the freedom of choice of the patients. The mean used to reach this goal, is to allow for private(both non-for profit and for profit) providers to apply for an approval to provide services “on behalf of” the public health care system, meaning that in the end, the government pays for the treatment. They introduced a new form of public-private partnership(PPP) within healthcare. Before this reform, tenders were used in the ppp part of the provision of healthcare, where the different health region have contracts with public providers that contain a lot more limitations, demands and conditions, than the new ppp relationships, where there is just an approval, and not an agreement with conditions regarding quantity of provision, for instance.  

To limit my project, I have chosen to focus on one health region in Norway, Helse Sør-Øst, and also to focus on one field where the reform was introduced very early, and also has been used to a somewhat large extend, in interdisciplinary specialized drug treatment, hereafter referred to as IST, which is long term alcohol and drug treatment.  

 

TSD

  • Ja

Biobank

  • Nei

Godkjenninger

Intern fremleggelse - Ja

Godkjent av: Oddvar Kaarbøe

REK - Ikke behov

Prosjektleder / prosjektansvarlig ved UiO

Oddvar Martin Kaarbøe

Ansvarlig enhet

Avdeling for helseledelse og helseøkonomi

Prosjekttype

  • Studentprosjekt – Bachelor-, master- eller spesialistoppgave

Helsefaglig forskning

  • Ja

Personopplysninger

  • Ikke besvart

Tidsperiode

  • Start: januar 2019
  • Slutt: juni 2019